Welcome to
The information on this site is tailored to Florida healthcare providers under Senate Bill SB1768.
By continuing, you confirm that:
You understand the material is intended for Florida physicians only.
The information on this site is tailored to Florida healthcare providers under Senate Bill SB1768.
By continuing, you confirm that:
You understand the material is intended for Florida physicians only.
Elizabeth (Liz) Parrish, MBA, is the Founder and CEO of BioViva Sciences USA Inc., a biotechnology company dedicated to extending healthy human lifespans through gene therapy. BioViva specializes in combinatorial gene therapies, leveraging its proprietary CMV gene therapy delivery platform to advance cutting-edge treatments.
A distinguished entrepreneur, author, and innovator, Liz is a leading advocate for the Best Choice Medicine (BCM) plan, a regulatory framework designed to streamline and accelerate the approval of genetic therapies. She is actively engaged in international educational outreach and has spoken at prestigious conferences worldwide, including WIRED, TEDx, and other high-profile forums.
Liz has been published in multiple books, including contributing an academic chapter to Springer, further solidifying her role as a thought leader in the field. She views cellular aging as a disease and believes that advancements in space research will not only contribute to healthier and longer lifespans but also enhance the safety of space travel and drive breakthroughs in curative medicine, particularly for patients under the age of 20.
From CHAT GPT - Liz Parrish is an entrepreneur and biohacker who is the founder and CEO of BioViva Sciences, a biotechnology company focused on developing gene therapies to treat age-related diseases. She is known for being the first person to undergo gene therapy to reverse biological aging, a procedure that was performed on her own body in 2015.
Parrish is a strong advocate for the use of gene therapies to improve human health and extend lifespan. She has spoken extensively about the potential of genetic engineering to address diseases such as cancer, Alzheimer's, and heart disease and has been involved in a number of research initiatives aimed at developing new gene therapies. Parrish is also an active member of the global biohacking community and has been involved in various initiatives aimed at promoting the responsible use of genetic engineering technologies.
ZEO ScientifiXTM supplies biologic products that let Florida physicians treat pain, orthopedics, and wound care with regulatory confidence.*
*Senate Bill 1768 became law in Florida on July 1, 2025 and amended FS §458.3245 and FS§459.0127, making stem cell therapies, as defined in the statute, available for the following therapeutic indications: orthopedics, wound care, and pain management.
*The material on this site is intended for general informational and educational purposes only and is not intended to provide medical advice, diagnosis, or treatment recommendations. ZEO ScientifiX doesn’t make any medical claims regarding any of these products. ZEO ScientifiX does not offer medical services to the public and does not endorse or guarantee any third-party products or services referenced. Content may reference investigational biologics or devices not approved by the FDA. If you are a patient please consult your physician for further information. Any mention of product usage are for therapeutic use only in the states of Florida and Utah. Certain information provided herein is intended only for those that may fall under the new Florida stem cell law in effect as of July 1, 2025. Subject to change without notice.
